Close Menu

NEW YORK (GenomeWeb) – Quanterix has raised $46 million in Series D funding from new and existing investors.

Three new investors — Trinitas Capital, Cormorant Asset Management, and Arch Overage Fund — led the round with continued participation from existing investors Arch Venture Partners, Bain Capital Ventures, Tufts University, and Quanterix scientific founder David Walt. Hercules Capital also participated in the round.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.